Head of Account Management

Location: 280 Summer St, Boston, MA 02210
Reports To: CEO
Employment Type: Full-Time, In-Office
Compensation:

Base Salary: $155,000–$180,000/year
On-Target Earnings: $200,000–$260,000

OTE is tied to net revenue retention, renewal rate, and expansion revenue across the client base. Uncapped upside for teams that beat plan.

About StemWave

StemWave is a fast-growing medical device company pioneering orthopedic shockwave technology in the U.S. We've been ranked among the fastest-growing privately held companies in 2023 and 2024. We sell into orthopedic, chiropractic, and physical therapy practices across the country, and our client base is growing faster than most teams can keep up with. Learn more: www.stemwave.com

The Opportunity

The best account management leaders don't wait to be handed a system. They build one, install it, and then make it impossible for the team to operate any other way.

That's the person we're looking for. Someone who has carried a number, beaten it, and then done it again through people they developed themselves. Someone who runs a rigorous operating cadence and can tell you the health of every account in the book without guessing. Someone who lives in Salesforce, knows exactly how to bend it to the way a team should actually work, and treats clean data as the foundation of every forecast rather than an administrative chore. If you've ever rebuilt a pipeline view because the default one was hiding the truth, you'll recognize yourself here.

You'll own retention and expansion outright. You will not carry your own book, which means every result you post comes from raising the ceiling on the people around you. That's the trade: no accounts to hide behind, and full credit when the team performs.

The upside is that you're walking into a market that's still wide open. Orthopedic shockwave therapy is early in the U.S., our client base is growing faster than any playbook we've written so far, and the systems you build now will run this function for years. Bring the standard, and we'll give you the room to set it.

What You'll Own

The number. Full ownership of net revenue retention, renewal rate, and expansion revenue across the entire client base. You forecast it, you defend it, you deliver it.
The team. Lead, coach, and develop a team of 7 Account Managers. Set the standard for activity, quality, and accountability, and hold the line on it.
The playbook. Build and install the systems that turn good AMs into great ones: call frameworks, onboarding standards, escalation paths, QBR structure, renewal motion, and expansion plays.
The bench. Recruit, interview, and onboard as we scale. You are building the org you'll be running in two years, including the managers who will report to you.
The coaching floor. Ride along on calls, sit in on renewals, and work at-risk accounts alongside your reps. Not because you own them, but because that's where coaching actually happens.
The cross-functional link. Partner with Sales on handoffs, with Operations on device deployment, and with the executive team on forecasting, headcount, and comp design.
The culture. Set the tone. This team should be the group everyone else in the building wants to be part of.

Your First 90 Days

Days 1–30: Know every AM, their strengths, and their gaps. Know the top accounts, the at-risk accounts, and why. Earn the team's trust by being in the work with them.
Days 31–60: Install your operating cadence: 1:1s, pipeline reviews, call coaching, and a scorecard every AM understands. Deliver a first honest read on where retention and expansion actually stand.
Days 61–90: Deliver an accurate forecast, a documented development plan for each AM, and a rebuilt playbook the team is running against.

What We're Looking For

8+ years in sales, account management, or client success, with a track record of consistently hitting or beating quota as an individual before you led
4+ years leading teams, ideally teams of 8 or more, with clear evidence you raised individual performance rather than inheriting it
Experience in a subscription, recurring revenue, or contract renewal environment (SaaS, medical device, or similar)
Fluency in the metrics that run this business: NRR, churn, LTV, MRR, renewal rate, and expansion
Real coaching ability. You can get on a call, hear exactly what went wrong, and teach the fix in a way that sticks
Presence. You are charismatic, approachable, and impossible to ignore. People want to be led by you, and they also know precisely where the bar is
The judgment to know when to develop someone and when to make a change, and the spine to do either
Comfort in a startup. You build the process rather than wait for it
CRM discipline (Salesforce, Monday.com, or equivalent) and the expectation that your team lives in the system
Experience in medical devices, orthopedics, or chiropractic care is a strong plus

Why This Role

Real ownership. You own a number, a team, and a playbook, with direct access to the executive team and no layers in between.
Scale in front of you. We are growing fast. Seven is the starting point, not the ceiling, and you will build the org chart above and below you.
Visible impact. Our clients treat patients who have run out of options. The work your team does puts this technology into practices that change outcomes.
Upside. Uncapped earnings tied to results you directly control.

Benefits

Paid vacation time & holidays
100% employer-paid medical, dental, and vision

At StemWave, we're not just building devices, we're building a movement. We're looking for the leader who will build the team that carries it.

About the company

StemWave manufactures a therapeutic device that clinics use to treat chronic and acute musculoskeletal pain. The system fires focused acoustic waves roughly 12 cm into tissue, delivering mechanical energy without heat or incisions; cells register the stimulus and respond by raising circulation and switching on repair pathways, a process called mechanotransduction that reduces pain and inflammation. Chiropractic, physical therapy, sports medicine, and pain practices buy the hardware and bill treatment as cash-pay, and the company sells training and service alongside it, reporting use in more than 1,200 clinics. Unlike injections, opioids, or surgery, the treatment is non-invasive and needs no recovery time. Its goal is to give providers a fourth option by making focused acoustic therapy routine.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify's Take

What believers are saying

SSRP’s April 2026 partnership adds credibility with regenerative-medicine clinicians.
The provider network and training program deepen customer adoption and repurchases.
StemWave’s non-invasive pain alternative fits clinics seeking surgery-avoiding patient volume.

What critics are saying

SoftWave TRT touts multiple FDA clearances and broader treatment claims in 2026.
StemWave’s $49 intro and uninsured $900 plans depend on discretionary clinic spending.
If clinicians choose cleared competitors, StemWave risks becoming a commodity device vendor.

What makes StemWave unique

StemWave sells an FDA-listed, non-invasive acoustic wave platform for musculoskeletal care.
On April 9, 2026, SSRP named StemWave a Trusted Partner.
Its Platinum Provider Program bundles education, business training, and marketing support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Company News

SSRP Institute

Apr 13th, 2026

SSRP Institute Welcomes StemWave as New Trusted Partner.

SSRP Institute Welcomes StemWave as New Trusted Partner. SSRP Institute PARTNER ANNOUNCEMENT. WILLOUGHBY, Ohio, [April 9, 2026] - The SSRP Institute announces that StemWave has joined its Trusted Partner Network following nomination and completion of the SSRP's internal review process. StemWave provides an FDA-listed, non-invasive acoustic wave therapy platform used in musculoskeletal care. The technology delivers focused mechanical energy to targeted tissues, supporting improved circulation, modulation of inflammatory signaling, and activation of the body's natural repair processes. It is commonly applied across soft tissue and joint-related conditions involving the shoulder, spine, hip, knee, ankle, foot, and associated tendons and ligaments. "StemWave's focused shockwave therapy has delivered exceptional clinical outcomes in my regenerative practice, with its ability to enhance tissue regeneration and activate natural healing. Their evidence-based approach and commitment to clinical excellence make them an ideal partner for the SSRP community," said Dr. Gerald Morris, SSRP nominating Member. From a cellular perspective, acoustic wave therapy influences microvascular perfusion, mechanotransduction pathways, and tissue remodeling. Research in shockwave therapy demonstrates improved blood flow and inflammation modulation, aligning with treatment goals for chronic pain and soft tissue dysfunction. Treatments are brief, non-pharmacologic, and designed to complement comprehensive regenerative care plans. "Rooted in science and performance, SSRP is spearheading a cultural shift in healthcare," says Jake Ellis of StemWave. "The values and transparency of this community made it an obvious partnership for us at StemWave! We're thrilled and grateful to amplify SSRP's mission with practical, evidence-driven tools, further fueling the highest standards in clinician support and patient outcomes." Through these partnerships, the SSRP aims to support Members by connecting them with vetted resources that complement training, protocol development, and implementation in practice. About the SSRP Institute. The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care. The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP's educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices. RELATED RESOURCES Continue exploring related topics. Cellular Medicine Mondays Apr 13, 2026 Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients Preview Only Journal Club - Episode 083 Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link) Cellular Medicine Mondays Apr 6, 2026 Ep. 082 - April '26 Preview Only Dr. Seeds' Office Hours - Episode 082 Mastermind Mastermind 15: The Aesthetic Matrix This course teaches a mechanism-informed approach to aesthetic skin aging by connecting environmental exposures and procedures with cellular stress, inflammation, and repair biology. You'll review how UVA and UVB contribute to photoaging, how visible/blue light is discussed in pigmentation and... 10 Lessons 17 hrs 24 min Cellular Medicine Mondays Mar 30, 2026 Ep. 081 - The Cellular Impact of UVA vs. UVB Light (Part 1) Preview Only Rabbit Holes - Episode 081 The Cellular Impact of UVA vs. UVB Light (Part 1) In this Rabbit Holes episode, Dr. Seeds explains the mechanistic differences between UVA and UVB light, highlighting how each spectrum uniquely contributes to photoaging, oxidative stress, DNA damage, and skin cancer risk. He also outlines cellular strategies to support antioxidant defenses, mitochondrial function, and DNA repair in response to chronic light exposure. Medivive Mar 27, 2026 SSRP Institute Welcomes Medivive as New Trusted Partner PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [March 27, 2026] - The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP's mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD[+] therapy designed to support cellular energetics through sterile, clinician-prescribed formulations [...] William Seeds, MD Mar 25, 2026 The Truth about Ketone Esters: Not All Exogenous Products are the Same The Father of Ketones and the Value of Exogenous Ketone Esters I've talked about ketones and ketone esters for many years, and I've now come to a place where I really have to take a more direct stand on how they've been marketed to the wider public, and in particular, to providers who may not [...] Cellular Medicine Mondays Mar 23, 2026 Ep. 080 - BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms Preview Only Dissecting Protocols - Episode 080 BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms Dr. Seeds reviews a case of swelling, joint stiffness, and tingling that appeared after stacking BPC-157 with TB-500, using it as a framework for thinking through peptide reactions, sourcing, and causality. (Question Link) Cellular Medicine Mondays Mar 16, 2026 Ep. 079 - Sleep Through the Lens of Cellular Medicine Preview Only Rabbit Holes - Episode 079 Sleep Through the Lens of Cellular Medicine In this episode of Rabbit Holes, Dr. Seeds discusses how light exposure, thermal regulation, and autonomic signaling influence sleep, circadian rhythm, and mitochondrial health through the lens of cellular medicine. SSRP Institute Mar 11, 2026 SSRP Institute Announces Troscriptions as New Trusted Partner PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [Mar 11, 2026] - The SSRP Institute today announced the addition of Troscriptions as its newest Trusted Partner, following nomination by SSRP Fellow Dr. Elizabeth Yurth and upon completion of the organization's internal clinical review and vetting process. Troscriptions offers physician-formulated, pharmaceutical grade, precision-dosed health optimization formulations delivered through a buccal [...] Cellular Medicine Mondays Mar 9, 2026 Ep. 078 - The Effects of AG1(R) Supplementation on the Gut Microbiome of Healthy Adults Preview Only Journal Club - Episode 078 The Effects of AG1(R) Supplementation on the Gut Microbiome of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Dr. Seeds reviews a randomized controlled study on AG1 and its potential impact on the gut microbiome. The research shows short-term probiotic survival and safety but no significant changes in microbiome diversity or systemic metabolic effects. Dr. Seeds discusses what the study supports, what it doesn't, and why careful interpretation of research matters in clinical practice. (Article Link) Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

Associated Press

Mar 3rd, 2026

DuBois pain clinic offers StemWave therapy, cutting pain scores from 7.56 to 3.83 in 12 weeks

Mercy Family Health has opened a pain management office in DuBois, Pennsylvania, featuring StemWave shockwave therapy as a non-invasive alternative to surgery and medication for chronic pain. Clinical data shows 85-90% of patients report sustained improvement, with pain scores dropping from 7.56 to 3.83 within 12 weeks. The therapy delivers high-energy impulses to painful tissue, stimulating cells to release healing factors and attracting the body's stem cells to the treatment site. The OrthoGold 100 device has received FDA clearance for pain relief and tissue activation. The treatment is not typically covered by insurance. Introductory sessions cost around $49, with full treatment plans ranging from $900 to higher amounts depending on session requirements. Patients can contact the clinic at 814-583-7792 to schedule consultations.

MENAFN

Feb 6th, 2024

Stemwave Unveils Platinum Provider Program: Elevating Education And Empowering Success For Clients

(MENAFN- GetNews) Boston - Feb 05, 2024 - StemWave, a trailblazer in non-invasive regenerative technology, is proud to introduce its latest initiative, the Platinum Provider Program.

StemWave

Head of Account Management

About the job